Together, this study suggests that the role of IL-17-producing RORγt+ ILCs in inducing inflammatory responses is not limited to inflammatory skin conditions such as psoriasis but contributes to other diseases such as cutaneous leishmaniasis. Here, IL17A is linked to psoriasis.